Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy...
Date First Received: March 7, 2007
Last Updated: April 21, 2008
Verified by: Alcon Research, April 2008
Clinical Trial Phase: Phase 4 | Start Date: May 2007
Overall Status: Completed
Estimated Enrollment: 750
Brief Summary
Official Title: “Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy”
Condition Keyword(s):
Intervention(s):
Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy.
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study
Study Primary Completion Date: August 2007
Intervention(s) in this Clinical Trial
- Drug: Travatan-Z
Outcome Measures for this Clinical Trial
Primary Measures
- Ocular Surface Disease Symptoms
Secondary Measures
- Intraocular pressure
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Adults with a clinical diagnosis of ocular hypertension, or primary open-angle, pigment dispersion or exfoliation glaucoma in at least one eye (study eye)
Exclusion Criteria:
- Age
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Alcon Research
Overall Clinical Trial Officials and Contacts
Mark Jasek, PhD Study Director Alcon Research
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00444665
Study ID Number: SMA-06-24
ClinicalTrials.gov Identifier: NCT00444665
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
